HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact
- PMID: 17634130
- PMCID: PMC1988803
- DOI: 10.1186/1742-6405-4-16
HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact
Abstract
A segment of the HIV infected population develops abnormal and excessive accumulation of adipose tissue in the trunk, including accumulation of visceral (deep abdominal) adipose tissue. This condition, known as HIV-related adipose redistribution syndrome (HARS), may also be accompanied by fat accumulation in the upper back/neck (dorsocervical region) and/or depletion of subcutaneous adipose tissue from the abdomen, face, limbs, or buttocks. HARS is estimated to occur in up to 32% of patients and is associated with health risks similar to those of metabolic syndrome. Techniques to detect and measure HARS include physician and patient assessments and radiologic or anthropometric methods.
Similar articles
-
HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanisms.AIDS Res Ther. 2007 Jun 27;4:14. doi: 10.1186/1742-6405-4-14. AIDS Res Ther. 2007. PMID: 17597538 Free PMC article.
-
Potential of recombinant human growth hormone in HIV-associated adipose redistribution syndrome.BioDrugs. 2000 Aug;14(2):83-91. doi: 10.2165/00063030-200014020-00002. BioDrugs. 2000. PMID: 18034560
-
Proven intra and interobserver reliability in the echographic assessments of body fat changes related to HIV associated Adipose Redistribution Syndrome (HARS).Curr HIV Res. 2008 Jun;6(4):276-8. doi: 10.2174/157016208785132509. Curr HIV Res. 2008. PMID: 18691025
-
Long-term changes in adipose tissue in human disease.Proc Nutr Soc. 2001 Aug;60(3):365-74. doi: 10.1079/pns200198. Proc Nutr Soc. 2001. PMID: 11681811 Review.
-
Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment.Biochim Biophys Acta. 2010 Mar;1801(3):392-9. doi: 10.1016/j.bbalip.2009.09.018. Epub 2009 Sep 30. Biochim Biophys Acta. 2010. PMID: 19800025 Review.
Cited by
-
Central obesity & dyslipidemia in HIV patients on antiretroviral therapy.Indian J Med Res. 2018 Oct;148(4):366-368. doi: 10.4103/ijmr.IJMR_1190_18. Indian J Med Res. 2018. PMID: 30665998 Free PMC article. No abstract available.
-
The Impact of a Health Promotion Educational Program on Cardiovascular Risk Factors for HIV Infected Women on Antiretroviral Therapy.J AIDS Clin Res. 2013 Feb 7;4:224. doi: 10.4172/2155-6113.1000224. J AIDS Clin Res. 2013. PMID: 24432191 Free PMC article.
-
Beneficial effects of physical activity in an HIV-infected woman with lipodystrophy: a case report.J Med Case Rep. 2011 Sep 5;5:430. doi: 10.1186/1752-1947-5-430. J Med Case Rep. 2011. PMID: 21892961 Free PMC article.
-
Psychosocial Correlates of Body Image and Lipodystrophy in Women Aging With HIV.J Assoc Nurses AIDS Care. 2020 Mar-Apr;31(2):157-166. doi: 10.1097/JNC.0000000000000139. J Assoc Nurses AIDS Care. 2020. PMID: 31842064 Free PMC article.
-
Assessment of ultrasound for use in detecting lipoatrophy in HIV-infected patients taking combination antiretroviral therapy.AIDS Patient Care STDS. 2009 Feb;23(2):79-84. doi: 10.1089/apc.2008.0118. AIDS Patient Care STDS. 2009. PMID: 19133752 Free PMC article.
References
-
- Powderly WG. Long-term exposure to lifelong therapies. J Acquir Immune Defic Syndr. 2002;29:S28–40. - PubMed
-
- Engelson ES, Kotler DP, Tan Y, Agin D, Wang J, Pierson RN, Jr, Heymsfield SB. Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging. Am J Clin Nutr. 1999;69:1162–1169. - PubMed
-
- Herry I, Bernand L, de Truchis P, Perronne C. Hypertrophy of the breasts in a patient treated with indinavir. Clin Infect Dis. 1997;25:937–938. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources